Comparison of Vaginal Progesterone Alone with Vaginal Progesterone in Combination with Alpha Lipoic Acid for Prevention of Preterm Birth

Authors

  • Bushra Ashraf Department Obstetrics and Gynecology, Allied Hospital ll Faisalabad, Pakistan.
  • Naureen Javed Department of Obstetrics and Gynecology, Allied Hospital ll Faisalabad, Pakistan.
  • Misbah Ashraf Department of Obstetrics and Gynecology, Allied Hospital ll Faisalabad, Pakistan.
  • Mahwish Afzal Department of Obstetrics and Gynecology, Allied Hospital ll Faisalabad, Pakistan.
  • Yasmeen Amin Department of Gynae and Obs, DHQ, Allied-II Hospital, Faisalabad, Punjab, Pakistan.

DOI:

https://doi.org/10.70749/ijbr.v3i5.780

Keywords:

Vaginal Progesterone, Alpha Lipoic Acid, Preterm Birth

Abstract

Background: The etiology of preterm labor is complicated. Fetal membrane activation, cervical abnormalities, abdominal pain, and spontaneous uterine contractions are all associated with an inflammatory response. Premature birth is closely connected with cervical shortening throughout the second quarter of pregnancy. We assessed the advantages of administering alpha lipoic acid to women who were deemed to be at risk of preterm delivery due to a history of preterm birth. Methods: Patients presenting at the Gynecology and Obstetrics Department, Allied Hospital, Faisalabad from Sep 2024 to 28 Feb 2025 were included in this prospective study. Group A patients were given vaginal suppository of micronized progesterone alone (Cyclogest 400 mg vaginal pessary) nightly before bedtime until delivery. Group B patients were given vaginal progesterone in combination with oral alpha lipoic acid; Cyclogest 400 mg vaginal pessary with 2 tablets Alapro (containing 300 mg alpha lipoic acid) daily until delivery. Efficacy of the treatment was assessed by the absence /presence of preterm births. Results: Among 140 pregnant females, 70 belonged to each group. In Group A, 66 patients delivered after 37 weeks while in Group B, 56 patients delivered after 37 weeks. (p-value <0.05). Conclusion: In our group of patients, oral alpha lipoic acid supplementation with vaginal progesterone was more efficacious than vaginal progesterone alone at preventing premature birth. During the course of treatment, no negative effects were found.

Downloads

Download data is not yet available.

References

Romero R, Espinoza J, Kusanovic JP, Gotsch F, Hassan S, Erez O, Chaiworapongsa T, Mazor M. The preterm parturition syndrome. BJOG 2006; 113: 17-42. https://doi.org/10.1111/j.1471-0528.2006.01120.x

Haas DM, Caldwell DM, Kirkpatrick P, McIntosh JJ, Welton NJ. Tocolytic therapy for preterm delivery: systematic review and network meta-analysis. BMJ 2012; 345: e6226. https://doi.org/10.1136/bmj.e6226

Romero R, Nicolaides KH, Conde-Agudelo A, O’Brien JM, Cetingoz E, Da Fonseca E, Creasy GW, Hassan SS. Vaginal progesterone decreases preterm birth ≤ 34 weeks of gestation in women with a singleton pregnancy and a short cervix: an updated meta-analysis including data from the OPPTIMUM study. Ultrasound Obs Gynecol 2016; 48: 308-317. https://doi.org/10.1002/uog.15953

Reed LJ, DeBusk BG, Gunsalus IC, Hornberger CS Jr. Crystalline alpha-lipoic acid; a catalytic agent associated with pyruvate dehydrogenase. Science 1951; 114: 93-94. https://doi.org/10.1126/science.114.2952.93

Wada H, Shintani D, Ohlrogge J. Why do mitochondria synthesize fatty acids? Evidence for involvement in lipoic acid production. Proc Natl Acad Sci U S A 1997; 94: 1591-1596. https://doi.org/10.1073/pnas.94.4.1591

Parente E, Colannino G, Ferrara P. Efficacy of magnesium and alpha lipoic acid supplementation in reducing premature uterine contractions. Open J Obstet Gynecol 2014; 4: 578-583. https://doi.org/10.4236/ojog.2014.49082

Monastra G, De Grazia S, Cilaker Micili S, Goker A, Unfer V. Immunomodulatory activities of alpha lipoic acid with a special focus on its efficacy in preventing miscarriage. Expert Opin Drug Deliv 2016; 13: 1695-1708. https://doi.org/10.1080/17425247.2016.1200556

Parente E, Colannino G, Picconi O, Monastra G. Safety of oral alpha-lipoic acid treatment in pregnant women: a retrospective observational study. Eur Rev Med Pharmacol Sci 2017; 21: 4219-4227.

Bokstrom H, Brannstrom M, Alexandersson M, Norstrom A. Leukocyte subpopulations in the human uterine cervical stroma at early and term pregnancy. Hum Reprod 1997; 12; 586-590. https://doi.org/10.1093/humrep/12.3.586

Vadillo-Ortega F, Estrada-Gutierrez G. Role of matrix metalloproteinases in preterm labour. BJOG 2005; 112 Suppl 1: 19-22. https://doi.org/10.1111/j.1471-0528.2005.00579.x

Calder AA. Prostaglandins and biological control of cervical function. Aust N Z J Obstet Gynaecol 1994; 34: 347-351. https://doi.org/10.1111/j.1479-828x.1994.tb01087.x

Kim HS, Kim HJ, Park KG, Kim YN, Kwon TK, Park JY, Lee KU, Kim JG, Lee IK. Alpha-lipoic acid inhibits matrix metalloproteinase-9 expression by inhibiting NF-kappaB transcriptional activity. Exp Mol Med 2007; 39: 106-113. https://doi.org/10.1038/emm.2007.12

Moore RM, Novak JB, Kumar D, Mansour JM, Mercer BM, Moore JJ. Alpha-lipoic acid inhibits tumor necrosis factor-induced remodeling and weakening of human fetal membranes. Biol Reprod 2009; 80: 781-787. https://doi.org/10.1095/biolreprod.108.073205

Moore RM, Schatz F, Kumar D, Mercer BM, Abdelrahim A, Rangaswamy N, Bartel C, Mansour JM, Lockwood CJ, Moore JJ. Alpha-lipoic acid inhibits thrombin-induced fetal membrane weakening in vitro. Placenta 2010; 31: 886-892. https://doi.org/10.1016/j.placenta.2010.07.012

Li G, Fu J, Zhao Y, Ji K, Luan T, Zang B. Alpha-lipoic acid exerts anti-inflammatory effects on lipopolysaccharide-stimulated rat mesangial cells via inhibition of Nuclear Factor Kappa B (NF-κB) signaling pathway. Inflammation 2015; 38: 510-519. https://doi.org/10.1007/s10753-014-9957-3

Choi JH, Cho SO, Kim H. α-Lipoic acid inhibits expression of IL-8 by suppressing activation of MAPK, Jak/Stat, and NF-κB in H. pylori-infected gastric epithelial AGS cells. Yonsei Med J 2016; 57: 260-264. https://doi.org/10.3349/ymj.2016.57.1.260

Tanaka Y, Kaibori M, Miki H, Nakatake R, Tokuhara K, Nishizawa M, Okumura T, Kwon AH. Alpha-lipoic acid exerts a liver-protective effect in acute liver injury rats. J Surg Res 2015; 193: 675-683. https://doi.org/10.1016/j.jss.2014.08.057

Porcaro G, Brillo E, Giardina I, Di Iorio R. Alpha lipoic acid (ALA) effects on subchorionic hematoma: preliminary clinical results. Eur Rev Med Pharmacol Sci 2015; 19: 3426-3432.

Costantino M, Guaraldi C, Costantino D. Resolution of subchorionic hematoma and symptoms of threatened miscarriage using vaginal alpha lipoic acid or progesterone: clinical evidences. Eur Rev Med Pharmacol Sci 2016; 20: 1656-1663.

Grandi G, Pignatti L, Ferrari F, Dante G, Neri I, Facchinetti F. Vaginal alpha-lipoic acid shows an anti-inflammatory effect on the cervix, preventing its shortening after primary tocolysis. A pilot, randomized, placebo-controlled study. J Matern Fetal Neonatal Med 2017; 30: 2243-2249. https://doi.org/10.1080/14767058.2016.1245282

Downloads

Published

2025-05-14

How to Cite

Ashraf, B., Javed, N., Ashraf, M., Afzal, M., & Amin, Y. (2025). Comparison of Vaginal Progesterone Alone with Vaginal Progesterone in Combination with Alpha Lipoic Acid for Prevention of Preterm Birth. Indus Journal of Bioscience Research, 3(5), 337–340. https://doi.org/10.70749/ijbr.v3i5.780

Issue

Vol. 3 No. 5 (2025): Indus Journal of Bioscience Research

Section

Original Article

License

Copyright (c) 2025 Indus Journal of Bioscience Research

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.